How to Register Korean Cosmetics with the FDA Under MoCRA: A Founder’s Step-by-Step Guide (2026)

By the ALTA MEET editorial team | K-beauty ODM consulting

Most first-time founders discover MoCRA the hard way: after they have signed an ODM contract, approved a formula, and started production. That is roughly $15,000 into the process. The conversation usually begins with a panicked email that says something like, "My freight forwarder is asking for my FDA registration number. What is that?"

Since December 2023, the Modernization of Cosmetics Regulation Act (MoCRA, Public Law 117-328) has required every cosmetic product sold in the United States to be registered with the FDA. If your Korean ODM partner is manufacturing product that will touch U.S. soil, you need to understand MoCRA before you finalize your purchase order, not after.

This guide walks through the registration process step by step, covers the costs most founders underestimate, and explains how the requirements differ if you also plan to sell into the EU or keep your products compliant with Korea's MFDS framework.

Who Needs to Register (And Who Might Be Exempt)

MoCRA applies to every person that owns or operates a facility manufacturing or processing cosmetic products for U.S. distribution. For indie founders working with a Korean ODM, this typically means two entities need to be on file:

Your Korean ODM facility. The manufacturing site where your product is physically produced must be registered with the FDA. Most established Korean ODMs (those producing for global markets) already hold an FDA Establishment Identifier (FEI). If yours does not, that is a due-diligence flag worth investigating before you sign.

You, as the Responsible Person. Under MoCRA, the "responsible person" is the entity whose name appears on the product label. For most indie founders, that is your brand's legal entity (your LLC or corporation registered in the United States).

There is a small business exemption. If your average gross annual U.S. cosmetic sales fall below $1,000,000 over the preceding three years (adjusted annually for inflation), you may be exempt from facility registration, product listing, and GMP requirements. However, the exemption does not apply if your product contacts the mucous membrane of the eye, is injectable, is intended for internal use, or alters appearance for more than 24 hours without customary removal. Eye creams that market themselves for the "under-eye area" generally remain in the cosmetic category, but lash serums and certain eye treatments may cross into exempt-voiding territory. When in doubt, consult a regulatory attorney.

Even if you qualify for the small business exemption, you still need to comply with adverse event reporting and maintain records for at least three years.

What You Need Before You Start

Before you open the FDA's Cosmetics Direct portal, gather the following:

From your Korean ODM partner:

• The facility's FDA Establishment Identifier (FEI number). If they do not have one, they need to apply for it through the FDA's Unified Registration and Listing System (FURLS) before your facility registration can proceed.

• Complete ingredient lists (INCI nomenclature) for every SKU, including fragrance, flavor, and color components.

• Manufacturing site address exactly as it appears on the FEI record.

From your side:

• Your brand's legal entity name, U.S. business address, and contact information.

• A DUNS number (Data Universal Numbering System) for your business entity.

• Product category classifications for each SKU. The FDA uses a predefined list of cosmetic product categories, and choosing the right one matters for your listing accuracy.

• The brand names under which you will market each product.

A common mistake: founders assume their Korean ODM will handle the entire FDA registration process. Some full-service ODMs do offer regulatory support, but in our experience, about half of the ODM partners working with first-time founders expect the brand owner to manage U.S. regulatory filings independently. Clarify this during your initial negotiations, ideally in writing.

Step-by-Step: Registering Through Cosmetics Direct

The FDA launched Cosmetics Direct as the electronic submission portal for MoCRA compliance. The agency strongly recommends electronic submissions through this platform. Here is the process:

Step 1: Create your FDA account. Go to the FDA Industry Systems page and create an account. You will need a valid email and your business information. Processing typically takes one to three business days.

Step 2: Obtain or confirm your FEI number. Your Korean ODM facility needs an FEI. If the facility already manufactures products distributed in the U.S., it likely has one. If not, the facility owner or operator (or their authorized U.S. agent) must apply. A U.S. agent is required for any foreign facility, and this can be a regulatory consulting firm, a customs broker, or an individual physically located in the United States.

Step 3: Register the facility. Log into Cosmetics Direct and submit the facility registration. You will need: the facility owner's name, the facility address and contact information, the FEI number, all brand names for products manufactured at that facility, and the product categories for each cosmetic product manufactured there.

Step 4: List your products. For each SKU you intend to sell in the U.S., submit a product listing that includes: the FEI for every facility where the product is manufactured or processed, your name and contact information as the responsible person, the product category, a complete ingredient list (including fragrances, flavors, and colors), and the product listing number if one was previously assigned.

Step 5: Set your renewal calendar. As of February 2026, Cosmetics Direct displays two new fields: REGISTRATION STATUS and RENEWAL DATE. Facility registration must be renewed every two years from the date of initial registration. The FDA will send automated email reminders before your renewal date to the facility contact and the Cosmetics Direct account contact. You can choose between a full Biennial Renewal (if there are changes) or an Abbreviated Renewal (if nothing has changed).

The registration and listing process itself is free. The FDA does not charge a fee for Cosmetics Direct submissions. Your costs come from the time spent gathering documentation and, if you hire a regulatory consultant, their service fees.

The Costs Most Founders Miss

The Cosmetics Direct filing is free, but the regulatory compliance ecosystem around it is not. Here is what we typically see in 2026 quotations from regulatory service providers:

U.S. Agent designation for your Korean ODM facility: $500 to $2,000 per year. Your Korean facility needs a U.S.-based agent. Some ODMs already have one. If yours does not, you will need to arrange this.

Regulatory consulting (MoCRA filing support): $1,500 to $5,000 for initial setup, depending on the number of SKUs and complexity. This covers facility registration, product listing, and label compliance review.

Label compliance review: $300 to $800 per SKU. MoCRA requires specific labeling elements. Getting these wrong can result in a product being detained at customs.

Adverse event reporting system setup: $500 to $1,500. MoCRA requires a process for collecting and reporting serious adverse events within 15 business days. Most founders underestimate this requirement.

GMP documentation review: $1,000 to $3,000. While MoCRA's GMP requirements are still being finalized, having your ODM's ISO 22716:2007 certification and GMP documentation in order is a practical step. Most reputable Korean ODMs already operate under ISO 22716.

Total estimated regulatory cost for U.S. entry (first year, 3 to 5 SKUs): $4,000 to $12,000, depending on whether your ODM already has U.S. registration infrastructure in place.

I'm Liz. I run ALTA MEET from Brooklyn, NYC. When I launched my first K-beauty line, the MoCRA filing itself took about two hours. But sorting out the documentation with my ODM partner in Seoul took three weeks of back-and-forth emails because we did not discuss regulatory handoffs at the start. If you want a quick gut-check on whether your ODM partner is set up for U.S. compliance, I will give you 15 minutes free.

Email us: partnerships@altameet.com

If You Also Sell Into the EU: CPNP and the Responsible Person

Many indie founders selling Korean cosmetics in the U.S. also target the EU. The regulatory framework there is different, and in some ways more demanding.

Under EU Regulation (EC) No 1223/2009, every cosmetic product sold in the EU must have a designated Responsible Person (RP) physically established within the EU. The RP assumes legal responsibility for product compliance, including: compiling and maintaining the Product Information File (PIF), submitting product notification through the CPNP (Cosmetic Products Notification Portal), conducting post-market surveillance, and reporting serious undesirable effects to authorities.

You cannot sell a Korean-manufactured cosmetic in the EU without a designated RP whose name and address appear on your product label. Products found on the market without CPNP notification face immediate withdrawal orders. There is no grace period.

EU compliance costs (per product):

• Responsible Person service: approximately $400 to $600 per year for up to 5 products (varies by provider).

• Cosmetic Product Safety Report (CPSR): $350 to $3,000 per product, depending on formulation complexity and number of ingredients.

• CPNP notification filing: typically included in RP service fees, but some providers charge $100 to $300 per product separately.

• Product Information File (PIF) compilation: $500 to $2,000 per product if outsourced.

Total estimated EU regulatory cost (first year, 3 to 5 SKUs): $3,000 to $15,000.

The 2026 EU allergen disclosure update under Regulation (EC) No 1223/2009 adds new requirements for fragrance allergen labeling. If your Korean formulation contains common fragrance compounds, you may need reformulation or at minimum a label update to comply.

Korea Side: MFDS General vs. Functional Cosmetic Classification

Your Korean ODM handles MFDS (Ministry of Food and Drug Safety, formerly KFDA) compliance for products manufactured and sold within Korea. But understanding the Korean classification system matters for founders because it affects your formulation options and timeline.

Korea classifies cosmetics into two categories:

General cosmetics require no pre-market approval from MFDS. The manufacturer files a product report, and the product can go to market. This covers most skincare products: moisturizers, cleansers, toners, serums (without functional claims).

Functional cosmetics require prior approval or notification, along with submission of scientific supporting data to MFDS. Products making claims related to whitening (brightening), anti-wrinkle, sun protection, hair loss prevention, or skin color alteration fall into this category. The functional cosmetic review process typically adds 3 to 6 months and $8,000 to $15,000 in clinical testing and documentation costs.

Why this matters for U.S.-bound products: if your Korean ODM formulates a product with functional claims for the Korean market, the same formula exported to the U.S. may carry a different claim set. Brightening claims that require MFDS functional approval in Korea do not require equivalent FDA pre-market approval in the U.S. (cosmetics in the U.S. do not require pre-market approval, period), but they do need to stay within cosmetic claim boundaries rather than drifting into drug claims.

Common Mistakes That Cost Founders Time and Money

After working with founders navigating this process, these are the errors we see most often:

Assuming your ODM's Korean certifications cover U.S. compliance. Your ODM's MFDS registration and Korean GMP certification are excellent quality signals, but they do not substitute for MoCRA facility registration with the FDA. These are separate regulatory systems.

Waiting until product is ready to ship. U.S. Agent designation, FEI number acquisition (if needed), and Cosmetics Direct account setup can take 2 to 6 weeks collectively. Build this into your project timeline from the start.

Ignoring the adverse event reporting requirement. MoCRA requires you to report serious adverse events to the FDA within 15 business days. You need a functional system for collecting consumer complaints before your product reaches shelves, not after the first complaint arrives.

Treating FDA registration as a one-time task. Facility registration renewal is biennial. Product listings need annual updates. Set calendar reminders or you risk falling out of compliance.

Skipping the label review. Korean packaging designs often do not include all U.S.-required label elements. Retrofitting labels after production is expensive. Have your label reviewed for U.S. compliance before your ODM begins packaging runs.

Overlooking the KORUS advantage. The Korea-United States Free Trade Agreement (KORUS), in effect since March 2012, allows most Korean industrial and consumer goods, including cosmetics, to enter the U.S. duty-free. Many first-time founders do not realize this and budget for customs duties that may not apply. Confirm your product's HTS classification with a licensed customs broker to verify eligibility.

A Realistic Timeline: From ODM Contract to Compliant U.S. Launch

Here is what a realistic regulatory timeline looks like for a first-time founder importing 3 to 5 SKUs from a Korean ODM:

Weeks 1 to 2: Confirm your ODM's FEI status. If they already have one (common for ODMs exporting to the U.S.), this step is a simple verification. If they need one, add 2 to 4 weeks.

Weeks 2 to 4: Set up your FDA account, designate a U.S. Agent for your Korean facility (if not already in place), and register the facility through Cosmetics Direct.

Weeks 3 to 5: Submit product listings for each SKU. This requires finalized ingredient lists, so coordinate with your ODM to lock formulations before this step.

Weeks 4 to 6: Complete label compliance review. Address any gaps (ingredient list format, required warnings, net quantity declarations, distributor/responsible person information).

Weeks 5 to 8: Set up adverse event reporting procedures. Document your process for collecting, investigating, and reporting serious adverse events.

Concurrent with production (weeks 8 to 16): If you are also entering the EU, begin the RP designation and CPSR process. The CPSR alone can take 4 to 8 weeks depending on formulation complexity.

Total regulatory timeline (U.S. only): 6 to 10 weeks, running concurrently with production. If your ODM already has an FEI and U.S. Agent, this compresses to 3 to 6 weeks.

Total regulatory timeline (U.S. + EU): 10 to 18 weeks.

Key Takeaways

1. MoCRA requires FDA facility registration and product listing for every cosmetic sold in the U.S. The Cosmetics Direct portal is free to use, but surrounding compliance costs typically run $4,000 to $12,000 for 3 to 5 SKUs in the first year.

2. Your Korean ODM facility needs an FDA Establishment Identifier (FEI) and a designated U.S. Agent. Verify both before signing your manufacturing contract.

3. The small business exemption applies if your average annual U.S. cosmetic sales are below $1,000,000, but it does not cover adverse event reporting obligations or products in certain high-risk categories.

4. EU entry adds a Responsible Person requirement, CPSR safety reports, and CPNP notification. Budget $3,000 to $15,000 for 3 to 5 SKUs.

5. Korea's MFDS classifies cosmetics as general or functional. Functional claims (brightening, anti-wrinkle, SPF) add 3 to 6 months and $8,000 to $15,000 in clinical testing costs on the Korean side.

6. KORUS allows most Korean cosmetics to enter the U.S. duty-free. Confirm your HTS classification with a customs broker.

7. Start regulatory planning at the same time as your ODM contract negotiation, not after production begins.

   Frequently Asked Questions

   Does the FDA charge a fee for MoCRA registration?
   No. The FDA does not charge for facility registration or product listing through Cosmetics Direct. Your costs come from gathering documentation, hiring regulatory consultants if needed, and maintaining compliance infrastructure like adverse event reporting systems.

   My Korean ODM says they are already "FDA registered." Is that enough?
   It depends. If your ODM holds a valid FEI and their facility registration is current in Cosmetics Direct, that covers the facility side. But you, as the responsible person (the brand on the label), still need to submit product listings for your specific SKUs. Facility registration and product listing are separate requirements.

   Can I use the same Responsible Person for both the EU and UK markets?
   No. Since Brexit, the EU and UK operate as separate regulatory jurisdictions. You need a Responsible Person established in the EU for EU sales and a separate Responsible Person established in the UK for UK sales. Some service providers offer both, but they are legally distinct designations.

   What happens if I sell without registering?
   Your product can be detained at the U.S. border or flagged during a domestic inspection. The FDA has the authority to issue warning letters, detain products, and pursue enforcement actions for MoCRA violations. Beyond enforcement risk, major U.S. retailers increasingly require proof of MoCRA compliance before agreeing to stock a product.

   Do I need separate registrations for each SKU in a product line?
   You need one facility registration per manufacturing site, but a separate product listing for each distinct cosmetic product you sell. If your Korean ODM produces five SKUs for your brand, you register the facility once and submit five product listings.

   How does KORUS affect my import costs?
   Under the Korea-United States Free Trade Agreement, most Korean cosmetics qualify for duty-free entry into the U.S. This can save you 0% to 6.5% on customs duties compared to importing from non-FTA countries. However, you still pay the merchandise processing fee (MPF) and any applicable harbor maintenance fees. Work with a licensed customs broker to confirm your product's eligibility.

   Is ISO 22716 certification mandatory under MoCRA?
   MoCRA mandates Good Manufacturing Practice (GMP) for cosmetics, and the FDA has indicated that it will look to existing standards like ISO 22716:2007 as a baseline. While the FDA has not yet finalized its own GMP regulation under MoCRA, most Korean ODMs already hold ISO 22716 certification. Having this in place is both a practical compliance step and a strong signal to retailers and distributors.

   Working With ALTA MEET

   ALTA MEET connects indie beauty founders with vetted Korean ODM partners who already have U.S. and EU export infrastructure in place. Every ODM in our network holds ISO 22716 certification, maintains an active FDA FEI, and has designated U.S. Agents on file.

   If you are evaluating Korean ODM partners and want to understand their regulatory readiness before you commit, reach out for a free 15-minute consultation.

   Email us: partnerships@altameet.com

   Related reading on altameet.com:

   • Korean ODM vs OEM vs Private Label: Which Should Indie Founders Choose?

   • 5 Stability Tests Korean ODM Labs Run Before a Formula Ships

   Reviewed for accuracy by ALTA MEET's formulation consulting team.

   References:
   MoCRA (Modernization of Cosmetics Regulation Act of 2022, Public Law 117-328)
   FDA Cosmetics Direct portal and User's Guide (February 2026 update)
   FDA Guidance for Industry: Registration and Listing of Cosmetic Product Facilities and Products (December 2024 final guidance)
   Regulation (EC) No 1223/2009 (EU Cosmetic Regulation)
   ISO 22716:2007 (Cosmetics Good Manufacturing Practices)
   Korea MFDS Cosmetic Act (general vs. functional cosmetic classification)
   KORUS (Korea-United States Free Trade Agreement, effective March 15, 2012)